image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Our latest issue will be released in 10 days, don't miss out!

Playtech - Large eps upgrades simply not acknowledged by investors

November 2023

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • PTEC
  • Price:
  • 405p
It’s a strange turn of events when even after announcing forecast beating results some shares remain unchanged or are even marked down, turning conventional wisdom about the efficiency of markets on its head and illustrating the paralysis that’s gripped the market. But out of that malaise comes opportunities. One such example is gaming operator and software supplier to run gaming websites Playtech, which has seen its forecasts for 2023 rise from 37.5 cents to 60.1 cents - an upgrade in aggregate of 60%. For 2024 forecasts have also drifted up from 60.2 cents (49p) to 68.1 cents (56p). Behind its impressive earnings momentum has been a turnaround story that started out of a crisis back in 2017 when its unregulated Asian busi ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author